AEZ Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

43844 (AEZ.TO) Insider Trading History Chart

This chart shows the insider buying and selling history at 43844 (AEZ.TO) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

43844 (AEZ.TO) Share Price & Price History

Current Price: C$0.00
Price Change: +0.30 (1.20%)
As of 12/31/1969 07:45 PM ET

This chart shows the closing price history over time for AEZ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

43844 (AEZ.TO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/24/2021Klaus PauliniDirectorBuy15,000C$0.83C$12,474.0055,000
See Full Table

SEC Filings (Institutional Ownership Changes) for 43844 (AEZ.TO) (TSE:AEZ)

43844 (AEZ.TO) logo
Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.
Read More on 43844 (AEZ.TO)

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

1,000 shs

Average Volume

12,504 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A